Disturbances of the CD95 (APO-1/Fas) system in disorders of lymphohaematopoietic cells

Cell Death and Differentiation

Volumn 3, Issue 2, 1996, Pages 185-189

  Debatin, Klaus Michael ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

AIDS; APO 1; Apoptosis; Autoimmunity; CD95; Fas leukemias

Indexed keywords

FAS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CELL DEATH; CELL PROLIFERATION; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; LIGAND BINDING; LYMPHOPROLIFERATIVE DISEASE; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T CELL LEUKEMIA;

EID: 0029951071     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N and Nagata S (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature genetics 11: 294-299
2. Akashi K, Hayashi S, Gondo H, Mizuno SI, Tamura K, Yamasaki K, Shibuya T, Uike N, Okamura T, Miyamoto T and Niho Y (1994) Involvement of interferon-γ, and macrophage colony-stimulating factor in pathogenesis of hemophagocytic lymphohistiocytosis in adults. Br. J. Haematol. 87: 243-250
3. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell K and Lynch DH (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181: 71-77
4. Allen PD, Bustin SA and Newland AC (1993) The role of apoptosis in haemopoiesis and the immune system. Blood Rev. 7 (1): 63-73
5. Ameisen JC (1992) Programmed cell death and AIDS: from hypothesis to experiment. Immunol. Today 13: 388-391
6. Ameisen JC, Estaquier J, Idziorek T and De Bels F (1995) Programmed cell death and AIDS: significance, perspectives and unanswered questions. Cell Death Diff. 2: 9-22
7. Behrmann I, Walczak H and Krammer PH (1994) Structure of the human APO-1 gene. J. Immunol. 24: 3057-3062
8. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A and Duke RC (1995) A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632
9. Broome HE, Dargan CM, Krajewski S and Reed JC (1995) Expression of Bcl-2, Bcl-x, and Bax after T Cell Activation and II-2 Withdrawal. J. Immunol. 155: 2311-2317
10. Brunner T, Mogil RJ, LaFace D, Yoo NY, Mahboubl A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF and Green DR (1995) Cell-autonomous Fas (CD95)/Fas ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444
11. Carson DA and Ribeiro JM (1993) Apoptosis and disease. Lancet 341: 1251-1254
12. Cheng J, Zhou T, Liu C, et al. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762
13. Cleveland JL and Ihle JN (1995) Contenders in FasL/TNF Death Signaling. Cell 81: 479-482
14. Cohen JJ, Duke RC, Fadok VA and Sellins KS (1992) Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10: 267-293
15. Cohen PL and Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269
16. Debatin K-M, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A and Krammer PH (1994a) High expression of APO-1 (CD95) on T-lymphocytes from HIV infected children. Blood 83: 3101-3103
17. Debatin K-M, Goldmann CK, Bamford R, Waldmann TA and Krammer PH (1990) Monoclonal antibody-mediated apoptosis in adult T cell leukemia. Lancet 335: 497-500
18. Debatin K-M, Goldman CK, Waldmann TA and Krammer PH (1993) APO-1 induced apoptosis of leukemia cells from patients with adult T cell leukemia. Blood 81: 2972-2977
19. Debatin K-M and Krammer PH (1995) Resistance to apoptosis in T-ALL is determined by an anti-apoptotic program. Leukemia 9: 815-820
20. Debatin K-M, Süss D and Krammer PH (1994) Differential expression of APO-1 on human thymocytes: implications for negative selection. Eur. J. Immunol. 24: 753-758
21. Dhein J, Daniel PT, Trauth BC, Oehm A and Krammer PH (1992) Induction of apoptosis by a mAb anti-APO-1 class switch variants is dependent on cross linking of APO-1 cell surface antigens. J. Immunol. 149: 3166-3173
22. Dhein J, Walczak H, Bäumler C, Debatin K-M and Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/Fas (CD95). Nature 373: 438-441
23. Finkel TH and Banda NK (1994) Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? Curr. Opin. Immunol. 6: 605-615
24. Finkel TH, Tudor-Williams G, Banda NK, et al. (1995) Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Medicine 1: 129-134
25. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ and Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946
26. Fiucci G and Ruberti G (1994) Detection of polymorphisms within the FAS cDNA gene sequence by GC-clamp denaturing gradient gel electrophoresis. Immunogenetics 39: 437-439
27. Gougeon ML (1995) Does apoptosis contribute to CD4 T cell depletion in human immunodeficiency virus infection? Cell Death Diff. 2: 1-8
28. Gougeon ML and Montagnier L (1993) Apoptosis in AIDS. Science 260: 1269-1270
29. Griffith TS, Brunner T, Fletcher SM, Green DR and Ferguson TA (1995) Fas ligand induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192
30. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175: 331-340
31. Itoh N and Nagata S (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268: 10932-10937
32. Itoh N, Tsujimoto Y and Nagata S (1993) Effect of Bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151: 621-627
33. Itoh N, Yonehara S, Ishii A, et al. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243
34. Itzui S, Kelley VE, Masuda K, Yoshida H, Roths JB and Murphy ED (1984) Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133: 227-233
35. Ju S-T, Panka DJ, El-Khatib M, Sheer DH, Stanger BZ and Marshak-Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448
36. Kägi D, Vignaux F, Lederman B, Bürki K, Depraetere V, Nagata S, Hengartner H and Golstein P (1994) Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 265: 528-530
37. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA and Herzenberg LA (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus infected individuals. J. Exp. Med. 181: 2029-2036
38. Kerr JFR, Willie AH and Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257
39. Kinoshita T, Yokota T, Arai K-i and Miyajima A (1995) Suppression of apoptotic death in hematopoetic cells by signalling through the II-3/GM-CSF receptors. EMBO J.14, 2: 266-275
40. Klas C, Debatin K-M, Jonker RR and Krammer PH (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5: 625-630
41. Knipping E, Debatin K-M, Stricker K, Heilig B, Eder A and Krammer PH (1995) Identification of soluble APO-1 in supernatants of human B and T cell lines and increased serum levels in B and T cell leukemias. Blood 85, 6: 1562-1569
42. Krammer PH, Behrmann I, Daniel P, Dhein J and Debatin K-M (1994a) Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6: 279-289
43. Krammer PH and Debatin K-M (1992) When apoptosis fails. Current Biol. 2: 383-385
44. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter ME and Debatin K-M (1994b) The role of APO-1 mediated apoptosis in the immune system. Immunol. Rev. 142: 175-191
45. Lücking-Famira KM, Daniel PT, Möller P, Krammer PH and Debatin K-M (1994) APO-1 (CD95) Mediated apoptosis in human T-All engrafted in SCID mice. Leukemia 8: 1825-1833
46. + human marrow cells is induced by Interferon γ and Tumor Necrosis Factor α and potentiates Cytokine-mediated hematopoetic suppression in vitro. Blood 85, 11: 3183-3190
47. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP and Miedema F (1992) Programmed death of T cells in HIV-1 infection. Science 257: 217-219
48. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K-i, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S and Loh DY (1995) Massive cell death of immature hematopoetic cells and neurons in Bcl-x-deficient mice. Science 267: 1506-1510
49. Nagata S and Golstein P (1995) The Fas death factor. Science 267: 1449-1456
50. Oehm A, Behrmann I, Falk W, et al. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267: 10709-10715
51. Owen-Schaub LB, Yonehara S, Crump WL and Grimm EA (1992) DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol. 140: 197-205
52. Pantel K and Nakeff A (1993) The role of lymphoid cells in hematopoetic regulation. Exp. Hematol. 21: 738-742
53. Peter ME, Kischkel FC, Hellbardt S, Chinnaiyan AE, Krammer PH and Dixit VM (1996) CD95 (APO-1/Fas) associating proteins and other members of this protein family. Cell Death Diff. In press
54. Raff M (1992) Social controls on cell survival and death. Nature 356: 397-400
55. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y and Jacobson MD (1993) Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262: 695-700
56. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR and Lynch DH (1994) gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24: 928-933
57. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin K-M, Fischer A and De Villartay JP (1995) Apo-1/Fas (CD95) mutations in human lymphoproliferative syndrome associated with autoimmunity and defective apoptosis. Science 268: 1347-1349
58. Russell JH, Rush B, Weaver C and Wang R (1993) Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90: 4409-4413
59. Russell JH and Wang R (1993) Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 23: 2379-2382
60. Rusten LS, Smeland EB, Jacobsen FW, Lien E, Lesslaude W, Loetscher H, Dubois CM and Jacobsen CEW (1994) Tumor necrosis factor-a inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. J. Clin. Invest. 94: 165-172
61. Sachs L and Lotem J (1993) Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 82, 1: 15-21
62. Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler-Stevenson M and Strober W (1992) A novel lymphoproliferative/autoimmune syndrome resembling Murine lpr/gld disease. J. Clin. Invest. 90: 334-341
63. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267: 1445-1449
64. Suda T, Takahashi T, Golstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75: 1169-1178
65. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T and Nagata S (1994a) Human fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6: 1567-1574
66. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Lopeland NG, Suda T and Nagata S (1994b) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976
67. Tanaka M, Suda T, Takahashi T and Nagata S (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14: 1129-1135
68. Tartaglia LA, Ayres TM, Wong GHW and Goeddel DV (1993) A novel domain within the 55 kD TNF receptor signals cell death. Cell 74: 845-853
69. Tartaglia L and Goeddel DV (1992) Tumor necrosis factor receptor signaling. J. Biol. Chem. 267: 4304-4307
70. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462
71. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305
72. Veis DJ, Sorenson CM, Shutter, JR and Korsmeyer SJ (1993) Bcl-2-Deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240
73. Viale M, Merli A and Bacigalupo A (1991) Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients. Blood 78: 1268-1274
74. Watanabe Fukunaga R, Brannan CL, Copeland NG, Jenkins NA and Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
75. Westendorp MO, Frank R, Stricker K, Dhein J, Walczak H, Debatin K-M and Krammer PH (1995) The mechanism of HIV-1 Tat and gp120-sensitized T cell apoptosis. Nature 375: 497-500
76. Williams GT and Smith CA (1993) Molecular regulation of apoptosis: genetic controls of cell death. Cell 74: 777-779
77. Williams GT, Smith CA, Spooncer E, Dexter TM and Taylor DR (1990) Hemopoetic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343: 76-79
78. Zoumbos NC, Djeu JY and Young NS (1984) Interferon is the suppressor of hematopoesis generated by stimulated lymphocytes in vitro. J Immunol 133: 769-774
79. Zoumbos N, Gascon P, Djeu J and Young NS (1985) Interferon is a mediator of hematopoetic suppression in aplastic anemia in vitro and possibly in vivo. Proc. Natl. Acad. Sci. USA 82: 188-192